Search

everythinglearnresearchcommunity

for

Search:↓

Chronotherapy is more effective than traditional treatment for alopecia areata.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Scalp cooling can help prevent hair loss from chemotherapy without raising cancer spread risk.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Women who had cancer treatment feel both positive and negative about their bodies.

New treatments like nanotechnology show promise in improving skin cancer therapy.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.